查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1641769

全球快速生育和妊娠检测套组市场（按产品、测试类型和最终用户划分）- 机会分析和产业预测，2024 年至 2033 年

Fertility and Pregnancy Rapid Test Kits Market By Product , By Test Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 240 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计快速不孕症和妊娠检测套组市场规模将在 2023 年达到 15 亿美元，到 2033 年将达到 31 亿美元，2024 年至 2033 年的复合年增长率为 7.4%。

生育与妊娠快速检测试剂盒市场-IMG1

快速不孕症和怀孕检测套组是市售的诊断工具，旨在快速检测尿液或唾液中的激素，以指示女性的不孕状况或怀孕情况。这些测试为个人提供了一种方便且私密的方式来监测他们的生殖健康，而无需医疗保健专业人员的干预。妊娠检测套组可检测人类绒毛膜促性腺激素分泌（一种在怀孕期间产生的激素）的存在，而不孕症检测套组可检测黄体激素和雌激素，这对排卵很重要。

全球快速不孕不育和妊娠检测套组市场预计将出现强劲增长，原因包括人们对生殖健康的认识不断提高以及在家检测的便利性，尤其是那些希望怀孕的人。 。此外，由于生活型态因素和延迟生育导致的不孕不育率急剧上升，希望怀孕的夫妻对不孕症检测套组的需求也随之增加。根据世界卫生组织 (WHO) 今天发布的 2023 年调查，大约 17.5% 的成年人口患有不孕症。 2024 年不孕症统计数据显示，全球整体有 4,850 万对夫妇患有不孕症。这凸显了对不孕症检测套组的迫切需求，以帮助个人监测他们的生育週期并做出明智的决定。此外，快速不孕症和妊娠检测套组相对便宜，对于希望监测生育能力而不需要频繁就医的个人来说，这是一种经济实惠的选择，从而显着推动了市场成长。此外，这些套件在实体店和线上市场均广泛销售，消费者可以轻鬆获得，进一步促进了市场的成长。早期检测妊娠，特别是对于月经不规则的女性和想要快速确认妊娠的女性来说，进一步增加了对妊娠检测套组的需求。儘管取得了进步，但一些检测套组仍然会出现假阳性和假阴性结果，这对市场成长造成了重大阻碍。此外，其他生殖健康技术的兴起，如数位排卵追踪器和提供更详细见解的行动应用程序，可能会减少对传统检测套组的需求，从而抑制市场成长。相反，更高的准确度、用户友好的设计和更快的结果等检测套组技术的创新正在扩大这些产品的吸引力和可靠性，预计这将在预测期内推动全球市场的扩张。此外，随着意外怀孕负担的增加和堕胎率的惊人上升，政府采取措施提高人们对妊娠测试作为预防措施的认识，预计将为未来几年的市场增长铺平新的道路。根据世界计划生育组织2022年发布的一项调查显示，41个国家约有50%的女性使用避孕器来防止怀孕。其中22个位于撒哈拉以南非洲。

全球快速不孕症和妊娠检测套组市场根据产品、测试类型、最终用户和地区进行细分。根据产品，市场分为快速妊娠检测套组和快速不孕症检测套组。依检测类型，分为尿液检测套组盒和血液检测检测套组。根据最终用户，市场可分为医院、居家医疗机构和其他。按地区分析，涵盖北美、欧洲、亚太、拉丁美洲以及中东和非洲。

主要发现

根据产品，快速妊娠测试领域预计将在 2024 年至 2033 年期间占据市场主导地位。

根据测试类型，尿液检查快速测试套件预计在预测期内呈现最高增长。

根据最终用户，居家医疗领域预计在预测期内将大幅成长。

根据地区，快速生育和妊娠检测套组市场预计未来几年在北美将强劲成长。

此报告可自订。 （需支付额外费用和时间安排。）

  • 新产品开发/主要企业的产品矩阵
  • 监管指南
  • 根据客户兴趣提供额外的公司简介
  • 按国家或地区进行的额外分析 - 市场规模和预测
  • 平均售价分析/价格分布分析
  • 扩展公司简介列表
  • 历史市场资料
  • Excel 格式的主要企业详细资料（包括位置、联络资讯、供应商/供应商网路等）

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 重大投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会

第四章 快速生育和妊娠检测套组市场（按产品）

  • 市场概况
  • 快速妊娠检测套组
  • 快速生育力检测套组

第 5 章快速生育和妊娠检测套组市场（按测试类型）

  • 市场概况
  • 尿液检查套件
  • 血液检测套组
  • 其他的

第六章 快速生育和妊娠检测套组市场（按最终用户）

  • 市场概况
  • 医院
  • 居家医疗
  • 其他的

第七章快速生育和妊娠检测套组市场（按地区）

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国快速生育和妊娠检测套组市场
    • 加拿大快速生育和妊娠检测套组市场
    • 墨西哥的快速生育和妊娠检测套组市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国快速生育和妊娠检测套组市场
    • 法国快速不孕及妊娠检测套组市场
    • 英国快速生育和妊娠检测套组市场
    • 义大利快速生育和妊娠检测套组市场
    • 西班牙快速生育和妊娠检测套组市场
    • 其他欧洲国家快速生育和妊娠检测套组市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本快速不孕及妊娠检测套组市场
    • 中国快速不孕不育及妊娠检测套组市场
    • 印度快速生育与妊娠检测套组市场
    • 澳洲快速生育和妊娠检测套组市场
    • 韩国快速生育和妊娠检测套组市场
    • 亚太地区其他快速生育和妊娠检测套组市场
  • 拉丁美洲、中东和非洲
    • 主要市场趋势和机会
    • 巴西的快速生育和妊娠检测套组市场
    • 沙乌地阿拉伯的快速生育和妊娠检测套组市场
    • 南非快速生育和妊娠检测套组市场
    • 拉丁美洲其他地区、中东和非洲快速生育和妊娠检测套组市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品映射
  • 竞争仪錶板
  • 竞争热图
  • 2023年主要企业的定位

第九章 公司简介

  • Atlas Medical GmbH
  • Church And Dwight Co., Inc.
  • Everlywell, Inc.
  • Geratherm Medical AG
  • QuidelOrtho Corporation
  • Mylab Discovery Solutions Pvt. Ltd.
  • Salignostics
  • Abbott
  • SPD Swiss Precision Diagnostics GmbH
  • AdvaCare Pharma
简介目录
Product Code: A324421

The fertility and pregnancy rapid test kits market was valued at $1.5 billion in 2023, and is projected to reach $3.1 billion by 2033, growing at a CAGR of 7.4% from 2024 to 2033.

Fertility and Pregnancy Rapid Test Kits Market - IMG1

Fertility and pregnancy rapid test kits are over-the-counter diagnostic tools designed to quickly detect hormones in urine or saliva that indicate a woman's fertility status or pregnancy. These tests provide a convenient and private way for individuals to monitor their reproductive health without the need for a healthcare professional's intervention. Pregnancy test kits detect the presence of human chorionic gonadotropin, a hormone produced during pregnancy, while fertility test kits detect luteinizing hormone or estrogen, which are critical for ovulation.

The global fertility and pregnancy rapid test kits market is witnessing robust growth due to factors such as rise in awareness about reproductive health and the convenience of at-home testing, especially among individuals trying to conceive. In addition, alarming rise in infertility rates due to lifestyle factors and delayed childbearing is driving a greater need for fertility test kits among couples seeking to conceive. According to a study published today by the World Health Organization in 2023, around 17.5% of the adult population experience infertility. The Infertility Statistics 2024 revealed that 48.5 million couples experience infertility globally. This highlights the urgent need for fertility test kits to help individuals monitor their fertility cycles and make informed decision. Moreover, the market growth is significantly driven by the relatively low cost of fertility and pregnancy rapid test kits makes them an affordable option for individuals seeking to monitor their reproductive health without the expense of frequent doctor visits. Furthermore, the widespread availability of these kits in both physical retail stores and online marketplaces makes them easy for consumers to access, thus contributing to the market growth. Early detection of pregnancy, especially for women with irregular cycles or those who want to confirm pregnancy quickly, is further augmenting the demand for pregnancy test kits. Despite advancements, some test kits may still provide false positives or false negatives, which significantly hampers the market growth. In addition, rise of other reproductive health technologies, such as digital ovulation trackers or mobile apps that offer more detailed insights, may reduce the demand for traditional test kits, thereby restraining the market growth. On the contrary, innovations in test kit technology, including greater accuracy, user-friendly designs, and faster results, have expanded the appeal and reliability of these products, which are expected to offer remunerative opportunities for the expansion of the global market during the forecast period. In addition, government initiatives to increase awareness about pregnancy testing as a preventative measure due to rise in burden of unplanned pregnancies and alarming rise in rate of abortion are anticipated to open new avenues for the growth of the market in the coming years. According to a 2022 study published by the World Family Planning, approximately 50% of the women across 41 countries use contraceptives to prevent pregnancy. Among these, 22 countries were from sub-Saharan Africa alone.

The global fertility and pregnancy rapid test kits market is segmented into product, test type, end user, and region. On the basis of the product, the market is bifurcated into pregnancy rapid tests and fertility rapid tests. By test type, it is classified into urine-based test kits and blood-based test kits. Depending on end user, it is divided into hospitals, homecare settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the pregnancy rapid tests segment is expected to dominate the market from 2024 to 2033.

On the basis of test type, the urine-based test kits rapid tests segment is anticipated to exhibit the highest growth during the forecast period.

Depending on end user, the homecare settings segment is projected to grow at a notable pace throughout the forecast period.

Region wise, the fertility and pregnancy rapid test kits market is likely to witness strong growth in In North America in the coming years.

Competition Analysis

Competitive analysis and profiles of the major players in the global fertility and pregnancy rapid test kits market include Atlas Medical GmbH, Church & Dwight Co., Inc., Everlywell, Inc., Geratherm Medical AG, QuidelOrtho Corporation, Mylab Discovery Solutions Pvt. Ltd., Salignostics , Abbott, SPD Swiss Precision Diagnostics GmbH, and AdvaCare Pharma. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Pregnancy Rapid Tests
  • Fertility Rapid Tests

By Test Type

  • Urine-based Test Kits
  • Blood-based Test Kits
  • Others

By End User

  • Hospitals
  • Homecare Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Atlas Medical GmbH
    • Church & Dwight Co., Inc.
    • Everlywell, Inc.
    • Geratherm Medical AG
    • QuidelOrtho Corporation
    • Mylab Discovery Solutions Pvt. Ltd.
    • Salignostics
    • Abbott
    • SPD Swiss Precision Diagnostics GmbH
    • AdvaCare Pharma

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Pregnancy Rapid Tests
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Fertility Rapid Tests
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY TEST TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Test Type
  • 5.2. Urine-based Test Kits
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Blood-based Test Kits
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Homecare Settings
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Test Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Fertility and Pregnancy Rapid Test Kits Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Test Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Fertility and Pregnancy Rapid Test Kits Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Test Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Fertility and Pregnancy Rapid Test Kits Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Test Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Test Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Test Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Test Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Test Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Test Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Test Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest Of Europe Fertility and Pregnancy Rapid Test Kits Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Test Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Test Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Test Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Test Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Test Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Test Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Test Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Fertility and Pregnancy Rapid Test Kits Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Test Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Test Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Test Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Test Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Test Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Fertility and Pregnancy Rapid Test Kits Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Test Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping Of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Atlas Medical GmbH
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Church And Dwight Co., Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Everlywell, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Geratherm Medical AG
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. QuidelOrtho Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Mylab Discovery Solutions Pvt. Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Salignostics
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Abbott
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. SPD Swiss Precision Diagnostics GmbH
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. AdvaCare Pharma
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments